The Latest Breaking News from FDA

Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.

Snack foods are a pantry staple in most homes. We trust that the chips, crackers, cookies, and bars we buy are safe to eat. However, snack products are frequently the subject of national food recalls. These recalls occur when a product is found to pose a potential health risk to…

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

Nektar Therapeutics soared 157% after Rezpeg succeeded in a Phase 2b eczema trial. Analysts forecast huge upside—here’s why there could be more gains ahead.

The Trump administration is continuing to make its imprint on U.S. vaccine policy in recent days

The Department of Health and Human Services under Robert F

FDA has updated safety warnings for the Pfizer-BioNTech (Comirnaty) and Moderna (Spikevax) COVID-19 vaccines.

A key vaccine policy advisory group is recommending the public not receive vaccines that have thimerosal, a mercury-containing preservative.

The history of mental health treatment is a complex and often unsettling journey. As our understanding of the human mind evolves, so do our standards for providing ethical and effective care. Many treatments that were once mainstream have since been abandoned by doctors. These older methods were often brutal, lacked…